Photoswitchable Small Molecules for Cancer Therapeutics: Mechanisms, Advances, and Challenges.
Spatial distribution of various functional groups in biologically active molecules greatly influences their affinity toward the targets.
APA
Ali S, Tyagi K, Venkatesh V (2026). Photoswitchable Small Molecules for Cancer Therapeutics: Mechanisms, Advances, and Challenges.. Chemistry, an Asian journal, 21(2), e01001. https://doi.org/10.1002/asia.202501001
MLA
Ali S, et al.. "Photoswitchable Small Molecules for Cancer Therapeutics: Mechanisms, Advances, and Challenges.." Chemistry, an Asian journal, vol. 21, no. 2, 2026, pp. e01001.
PMID
41603482
Abstract
Spatial distribution of various functional groups in biologically active molecules greatly influences their affinity toward the targets. This spatial distribution can be regulated by external stimuli such as ultrasound, light, etc. Photoswitches are one such example, where light induces isomerization, which leads to the formation of another isomeric form with higher affinity, at a particular wavelength. In this regard, utilizing the isomerization across a double bond under UV or visible light, various small-molecule-based photoswitchable anticancer agents are being designed, that show greater antiproliferative activity in one isomeric form over the other. Herein, some of the recent advances made in this direction have been compiled, which are being developed as potent therapeutics for a spectrum of cancer types.
MeSH Terms
Humans; Antineoplastic Agents; Neoplasms; Small Molecule Libraries; Cell Proliferation; Light; Isomerism; Photochemical Processes; Molecular Structure
같은 제1저자의 인용 많은 논문 (5)
- Compression and k-mer Based Approach for Anticancer Peptide Analysis.
- The distinct roles of and in proximal- and late-onset colorectal cancer.
- EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy.
- Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer.
- Commentary on: Efficacy and safety of stereotactic body radiation therapy in elderly patients with cirrhosis and large advanced hepatocellular carcinoma.